Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus

被引:14
作者
Fu, TM
Freed, DC
Trigona, WL
Guan, LM
Zhu, L
Long, R
Persaud, NV
Manson, K
Dubey, S
Shiver, JW
机构
[1] Merck Res Labs, Dept Virus & Cell Biol, West Point, PA 19486 USA
[2] Primedica, Worcester, MA 01608 USA
关键词
D O I
10.1128/JVI.75.1.73-82.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cytotoxic T-lymphocyte (CTL) responses have been implicated as playing an important role in control of human immunodeficiency virus (HIV) infection. However, it is technically difficult to demonstrate CTL responses consistently in nonhuman primate and human subjects using traditional cytotoxicity assay methods. In this study, we systematically evaluated culture conditions that may affect the proliferation and expansion of CTL effector cells and presented a sensitive method for detection of cytotoxicity responses with bulk CTL cultures. We confirmed the sensitivity and specificity of this method by demonstration of vigorous CTL responses in a simian-HIV (SHIV)-infected rhesus macaque. The expansion of epitope-specific CTL effector cells was also measured quantitatively by CTL epitope-major histocompatibility complex tetramer complex staining. In addition, two new T-cell determinants in the SIV gag region are identified. Last, we showed the utility of this method for studying CTL responses in chimpanzee and human subjects.
引用
收藏
页码:73 / 82
页数:10
相关论文
共 43 条
  • [1] Allen TM, 1998, J IMMUNOL, V160, P6062
  • [2] Phenotypic analysis of antigen-specific T lymphocytes
    Altman, JD
    Moss, PAH
    Goulder, PJR
    Barouch, DH
    McHeyzerWilliams, MG
    Bell, JI
    McMichael, AJ
    Davis, MM
    [J]. SCIENCE, 1996, 274 (5284) : 94 - 96
  • [3] Anton LC, 1997, J IMMUNOL, V158, P2535
  • [4] BENNINK JR, 1990, CURR TOP MICROBIOL, V163, P153
  • [5] MHC restriction in three dimensions: A view of T cell receptor/ligand interactions
    Bjorkman, PJ
    [J]. CELL, 1997, 89 (02) : 167 - 170
  • [6] Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
    Borrow, P
    Lewicki, H
    Wei, XP
    Horwitz, MS
    Peffer, N
    Meyers, H
    Nelson, JA
    Gairin, JE
    Hahn, BH
    Oldstone, MBA
    Shaw, GM
    [J]. NATURE MEDICINE, 1997, 3 (02) : 205 - 211
  • [7] VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    BORROW, P
    LEWICKI, H
    HAHN, BH
    SHAW, GM
    OLDSTONE, MBA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6103 - 6110
  • [8] THE EVALUATION OF LIMITING DILUTION ASSAYS
    DESTGROTH, SF
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1982, 49 (02) : R11 - R23
  • [9] Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers
    Ferrari, G
    Humphrey, W
    McElrath, MJ
    Excler, JL
    Duliege, AM
    Clements, ML
    Corey, LC
    Bolognesi, DP
    Weinhold, KJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) : 1396 - 1401
  • [10] Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: Implications for antigen-specific immunotherapy
    Ferrari, G
    Berend, C
    Ottinger, J
    Dodge, R
    Bartlett, J
    Toso, J
    Moody, D
    Tartaglia, J
    Cox, WI
    Paoletti, E
    Weinhold, KJ
    [J]. BLOOD, 1997, 90 (06) : 2406 - 2416